eXoZymes, Inc. 是一家處於開發階段的合成生化公司。公司總部位於加州莫農維亞,目前聘有31名全職員工。該公司在2024年11月13日上市。該公司開發了一個平台,提供控制和優化自然界自身生物過程的工具和見解,使其合作夥伴能以新的可持續且不污染的替代方案取代傳統的化學生產方法。Exozymes是利用AI工程技術研發的先進酶類,能在活細胞之外的生物反應器中繁盛生長。
EXOZ stock price ended at $10.22 on 星期五, after rising 2.20%
On the latest trading day Feb 13, 2026, the stock price of EXOZ rose by 2.20%, climbing from $10.15 to $10.22. During the session, the stock saw a volatility of 1.98%, with prices oscillating between a daily low of $10.10 and a high of $10.30. Notably, trading volume dropped by 826 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 1.3K shares were traded, equating to a market value of approximately $85.7M.